Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection

By J. Kwong, K. Schwartz, M. Campitelli, Hannah Chung, N. Crowcroft, T. Karnauchow, K. Katz, Dennis T. Ko, A. McGeer, D. McNally and 6 more. New England Journal of Medicine, 2018

995 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/4ce935c1d2bb621788a06cfaef45d052167f38c0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Rosenkranz
2. S. Schulman
3. Joshua A. Beckman
4. C. Iadecola

In Epidemiology

1. Harlan M. Krumholz
2. C. Iadecola

Citations in the corpus

• Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic (2020, background): “, similar to influenza) (5) or mimickers such as COVID-19 myopericarditis, an increase in STEMI activations would have been expected.”
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, background): “Such cases have been als o previously described with influenza or other viral illnesses, and have been attributed to a c mbination of SIRS as well as localized vascular/plaque inflammation (10,98,99).”
• Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. (2020, background): “NIH Stroke Scale score, median (IQR) 16 (6-23)”
• Cardiovascular complications in COVID-19 (2020, positive): “Severe systemic inflammation increases the risk of atherosclerotic plaque disruption and AMI [15, [30] [31] [32] [33] .”